Finnegan is an Associate sponsor of the American Conference Institute’s fifth annual biosimilars forum. Finnegan partner Susan Griffen will join the panel discussion “Ethics in the Biosimilars Realm: Avoiding Conflicts and Maintaining Confidentiality in the Brave New World." The program will take place at the InterContinental New York Barclay. For more information, or to register, please see ACI’s website.
